PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹3,766 Cr | ₹4,369 Cr | ₹3,851 Cr | ₹3,118 Cr | ₹2,591 Cr |
What is the latest Total Current Liabilities ratio of PIRAMAL PHARMA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹3,766 Cr |
| Mar2024 | ₹4,369 Cr |
| Mar2023 | ₹3,851 Cr |
| Mar2022 | ₹3,118 Cr |
| Mar2021 | ₹2,591 Cr |
How is Total Current Liabilities of PIRAMAL PHARMA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3,766 Cr | -13.80 | |
| Mar2024 | ₹4,369 Cr | 13.46 | |
| Mar2023 | ₹3,851 Cr | 23.51 | |
| Mar2022 | ₹3,118 Cr | 20.35 | |
| Mar2021 | ₹2,591 Cr | - | |
Compare Total Current Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹22,370.4 Cr | -6.9% | -3.6% | -29.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,037.0 Cr | -3% | -3.6% | -4.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,795.0 Cr | -3.1% | 0.1% | 11.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,332.0 Cr | -3.7% | 4% | 18.8% | Stock Analytics | |
| CIPLA | ₹116,933.0 Cr | -1.3% | -4.6% | -1.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,350.2 Cr | -4.2% | -7% | -11.4% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | -6.9% |
-3.6% |
-29.3% |
| SENSEX | -1.7% |
-1.4% |
7% |
You may also like the below Video Courses